0,761  0,016  Caspase 9 stimulant
0,729  0,009  Respiratory analeptic
0,683  0,008  5 Hydroxytryptamine release stimulant
0,664  0,004  Muscle relaxant
0,662  0,005  CYP2C19 inhibitor
0,655  0,004  Skeletal muscle relaxant
0,656  0,012  Antidepressant
0,644  0,005  Cardiodepressant
0,643  0,005  CYP2D6 inhibitor
0,649  0,013  Mood disorders treatment
0,642  0,009  Spasmolytic
0,643  0,025  Antineoplastic (lung cancer)
0,563  0,003  Neurotrophic factor enhancer
0,544  0,006  5 Hydroxytryptamine antagonist
0,550  0,016  Histamine release inhibitor
0,540  0,006  Sigma receptor agonist
0,547  0,014  Caspase 3 stimulant
0,546  0,018  Analeptic
0,520  0,009  Sedative
0,505  0,004  Alpha 2 adrenoreceptor antagonist
0,484  0,006  Antiparkinsonian, rigidity relieving
0,492  0,015  Antineoplastic (glioblastoma multiforme)
0,521  0,068  Apoptosis agonist
0,475  0,023  Antineoplastic (glioma)
0,468  0,021  Antineoplastic (non-small cell lung cancer)
0,449  0,008  5 Hydroxytryptamine 2 antagonist
0,472  0,040  Antineoplastic (colorectal cancer)
0,466  0,038  Antineoplastic (colon cancer)
0,426  0,004  Dopamine D1 antagonist
0,429  0,009  Male reproductive disfunction treatment
0,466  0,049  Antiparkinsonian
0,423  0,009  Alpha adrenoreceptor antagonist
0,443  0,032  Hepatic disorders treatment
0,438  0,030  Antineoplastic (brain cancer)
0,466  0,062  Antineoplastic (breast cancer)
0,411  0,008  Antiischemic, cerebral
0,408  0,007  5 Hydroxytryptamine 2A antagonist
0,420  0,029  Antineoplastic (multiple myeloma)
0,427  0,039  Antineoplastic (ovarian cancer)
0,394  0,008  Dopamine antagonist
0,430  0,045  Prostate cancer treatment
0,419  0,036  CYP1A2 substrate
0,392  0,018  Cyclic AMP phosphodiesterase inhibitor
0,384  0,013  Antineoplastic (squamous cell carcinoma)
0,424  0,057  Antileukemic
0,393  0,034  CYP3A4 inhibitor
0,366  0,007  Acetylcholine M1 receptor antagonist
0,359  0,005  Dopamine D3 antagonist
0,358  0,006  Alpha 2b adrenoreceptor antagonist
0,389  0,043  Antiischemic
0,391  0,046  Anxiolytic
0,356  0,013  Cholinergic
0,347  0,009  Dopamine D2 antagonist
0,346  0,008  Topoisomerase I inhibitor
0,377  0,048  Antipsychotic
0,362  0,037  DNA damaging
0,370  0,048  Antineoplastic (melanoma)
0,331  0,015  Topoisomerase II inhibitor
0,413  0,097  Antineoplastic (solid tumors)
0,326  0,011  Acetylcholinesterase inhibitor
0,318  0,006  Alpha 2a adrenoreceptor antagonist
0,331  0,022  Hepatoprotectant
0,321  0,013  Erectile dysfunction treatment
0,344  0,037  Antineoplastic (renal cancer)
0,319  0,014  Antiparkinsonian, tremor relieving
0,327  0,024  P-glycoprotein inhibitor
0,303  0,004  Acetylcholine M4 receptor antagonist
0,318  0,031  Abortion inducer
0,339  0,055  Antineoplastic (pancreatic cancer)
0,303  0,028  5 Hydroxytryptamine 1E antagonist
0,336  0,064  CYP2D6 substrate
0,283  0,013  Heat shock protein 90 antagonist
0,282  0,016  5 Hydroxytryptamine 2B antagonist
0,273  0,008  Phobic disorders treatment
0,277  0,015  Antiadrenergic
0,285  0,024  Antineoplastic (carcinoma)
0,328  0,067  Vasodilator, coronary
0,356  0,096  15-Lipoxygenase inhibitor
0,271  0,011  Uterine stimulant
0,312  0,054  CYP1A2 inhibitor
0,272  0,015  Adrenaline antagonist
0,337  0,083  CYP3A4 substrate
0,305  0,055  NOS2 expression inhibitor
0,271  0,024  MAO inhibitor
0,259  0,013  Acetylcholine muscarinic antagonist
0,254  0,014  Butyrylcholinesterase inhibitor
0,242  0,004  CDC-like kinase 3 inhibitor
0,241  0,005  Antineoplastic alkaloid
0,253  0,019  Acetylcholine antagonist
0,254  0,020  Cholinergic antagonist
0,243  0,011  Alpha 2c adrenoreceptor antagonist
0,249  0,018  CDC-like kinase 1 inhibitor
0,245  0,018  5 Hydroxytryptamine 3E antagonist
0,276  0,051  Antimitotic
0,301  0,078  Antineoplastic (small cell lung cancer)
0,237  0,018  DNA intercalator
0,235  0,016  Alpha 1 adrenoreceptor antagonist
0,217  0,005  Phosphodiesterase V inhibitor
0,240  0,029  Lipid peroxidase inhibitor
0,237  0,028  LDLR expression enhancer
0,248  0,041  Pneumotoxic
0,220  0,015  5 Hydroxytryptamine 1 antagonist
0,266  0,061  Antineoplastic (lymphoma)
0,290  0,086  12-Lipoxygenase inhibitor
0,207  0,004  Heat shock protein 90 beta antagonist
0,279  0,077  Hypoxia-inducible factor 1 alpha inhibitor
0,310  0,109  CYP2C9 inhibitor
0,223  0,025  MAO A inhibitor
0,210  0,014  5 Hydroxytryptamine 1A antagonist
0,291  0,099  Transcription factor NF kappa B inhibitor
0,227  0,036  Heat shock protein 90 alpha antagonist
0,217  0,032  Tubulin antagonist
0,208  0,023  MAO B inhibitor
0,197  0,014  Breast cancer-resistant protein inhibitor
0,241  0,062  Psychostimulant
0,185  0,007  Phosphodiesterase 5A inhibitor
0,210  0,032  Genotoxic
0,189  0,015  Calcium antagonist
0,236  0,062  Anticonvulsant
0,180  0,008  Acetylcholine M2 receptor antagonist
0,171  0,007  Phosphodiesterase 11A inhibitor
0,171  0,007  Phosphodiesterase XI inhibitor
0,203  0,041  Attention deficit/hyperactivity disorder treatment
0,172  0,010  Glutamate decarboxylase inhibitor
0,190  0,030  Antiviral (Hepatitis B)
0,170  0,010  Dual specificity tyrosine-phosphorylation regulated kinase 2 inhibitor
0,239  0,080  Tyrosine 3 hydroxylase inhibitor
0,195  0,037  Carcinogenic, group 1
0,278  0,122  Cognition disorders treatment
0,234  0,079  DNA synthesis inhibitor
0,198  0,044  Cystic fibrosis treatment
0,216  0,062  Nitric oxide antagonist
0,198  0,044  Toxic, respiratory center
0,275  0,127  CYP2C9 substrate
0,232  0,083  Antineoplastic (liver cancer)
0,151  0,007  Acetylcholine M5 receptor antagonist
0,181  0,037  Bipolar disorder treatment
0,227  0,085  Antineoplastic (cervical cancer)
0,213  0,075  Antineoplastic enhancer
0,192  0,055  Liver fibrosis treatment
0,151  0,016  5 Hydroxytryptamine uptake inhibitor
0,225  0,090  Myocardial infarction treatment
0,156  0,022  Topoisomerase II alpha inhibitor
0,255  0,123  Vasodilator, peripheral
0,230  0,098  Antineoplastic (bladder cancer)
0,161  0,031  Menstruation disorders treatment
0,211  0,084  RNA-directed DNA polymerase inhibitor
0,222  0,097  Antineoplastic (sarcoma)
0,135  0,011  Alpha tubulin antagonist
0,213  0,090  Antineoplastic (lymphocytic leukemia)
0,137  0,015  Restless leg syndrome treatment
0,200  0,081  Pyruvate kinase inhibitor
0,137  0,025  Alpha 1a adrenoreceptor antagonist
0,123  0,014  Acetylcholine M3 receptor antagonist
0,174  0,066  UGT1A3 substrate
0,137  0,029  DOPA decarboxylase inhibitor
0,115  0,009  AMPA receptor antagonist
0,247  0,142  Antiprotozoal (Plasmodium)
0,166  0,063  Melanin inhibitor
0,119  0,016  Female sexual dysfunction treatment
0,246  0,146  Stroke treatment
0,185  0,085  Antiarrhythmic
0,187  0,087  Clk dual-specificity kinase inhibitor
0,207  0,109  Antioxidant
0,215  0,118  CYP2C19 substrate
0,179  0,083  Platelet adhesion inhibitor
0,131  0,035  Dementia treatment
0,144  0,049  Antitussive
0,104  0,009  Glutamate (mGluR7) antagonist
0,119  0,025  Phosphodiesterase 6D inhibitor
0,153  0,061  CNS active muscle relaxant
0,120  0,028  5 Hydroxytryptamine agonist
0,127  0,034  Vascular dementia treatment
0,095  0,005  Ryanodine receptor antagonist
0,161  0,070  Antiviral (Herpes)
0,141  0,051  Adenylate cyclase inhibitor
0,208  0,118  UGT1A9 substrate
0,252  0,163  TNF expression inhibitor
0,154  0,066  Hearing loss treatment
0,214  0,127  Gastrin inhibitor
0,107  0,020  Beta tubulin antagonist
0,110  0,024  Nicotinic alpha4beta2 receptor antagonist
0,098  0,015  Alpha 2 adrenoreceptor agonist
0,184  0,103  Dual specificity tyrosine-phosphorylation regulated kinase 1A inhibitor
0,099  0,020  Acetylcholine M5 receptor agonist
0,176  0,099  Proto-oncogene tyrosine-protein kinase Fyn inhibitor
0,141  0,066  Antifungal enhancer
0,098  0,024  5 Hydroxytryptamine 1B antagonist
0,216  0,142  FMO3 substrate
0,238  0,166  GABA C receptor rho-3 antagonist
0,227  0,156  FMO1 substrate
0,077  0,007  Endothelin receptor antagonist
0,151  0,081  Thrombolytic
0,097  0,027  Dopamine D4 antagonist
0,097  0,029  Alpha adrenoreceptor agonist
0,173  0,105  Antihypertriglyceridemic
0,092  0,026  Phosphodiesterase VI inhibitor
0,149  0,083  Chemopreventive
0,128  0,063  Papain-like protease (SARS coronavirus) inhibitor
0,102  0,037  ATPase (Vacuolar H+) inhibitor
0,076  0,013  Dopamine D5 antagonist
0,077  0,014  5 Hydroxytryptamine 1B agonist
0,127  0,064  Antiviral (Papilloma)
0,181  0,120  Cytostatic
0,082  0,022  5 Hydroxytryptamine 5A antagonist
0,199  0,140  Radiosensitizer
0,078  0,020  Melanin-concentrating hormone receptor 1 antagonist
0,156  0,098  Sensitization
0,069  0,013  Adenylate cyclase 1 inhibitor
0,107  0,052  Estrogen receptor beta antagonist
0,091  0,036  T cell inhibitor
0,059  0,005  Endothelin B receptor antagonist
0,173  0,119  Antiprotozoal (Leishmania)
0,152  0,098  ATPase inhibitor
0,061  0,008  Phosphodiesterase 6C inhibitor
0,115  0,063  Sphingosine 1-phosphate receptor 2 agonist
0,097  0,047  5 Hydroxytryptamine 2C antagonist
0,078  0,028  5 Hydroxytryptamine 3 agonist
0,174  0,124  Antihypercholesterolemic
0,074  0,024  Postmenopausal disorders treatment
0,156  0,107  Anesthetic general
0,136  0,088  Ca2+-transporting ATPase inhibitor
0,075  0,027  Dopamine uptake inhibitor
0,068  0,021  5 Hydroxytryptamine 7 agonist
0,148  0,102  CDC-like kinase 4 inhibitor
0,237  0,191  Antineoplastic (myeloid leukemia)
0,071  0,025  5 Hydroxytryptamine 5 antagonist
0,200  0,156  Prostaglandin dehydrogenase inhibitor
0,167  0,123  VEGF expression inhibitor
0,128  0,085  Protein kinase stimulant
0,118  0,075  DNA repair enzyme inhibitor
0,080  0,037  Premenstrual syndrome treatment
0,048  0,006  Endothelin A receptor antagonist
0,073  0,032  Adrenaline uptake inhibitor
0,081  0,040  Antitreponemal
0,120  0,079  Antismoking
0,132  0,092  Dual specificity tyrosine-phosphorylation regulated kinase 1B inhibitor
0,109  0,069  Activin receptor-like kinase 4 inhibitor
0,089  0,049  mTOR complex 2 inhibitor
0,066  0,026  Bcl-xL inhibitor
0,068  0,029  Alpha 1 adrenoreceptor agonist
0,047  0,008  Phosphodiesterase 6B inhibitor
0,115  0,078  Antiseptic
0,062  0,024  Nicotinic alpha3beta2 receptor antagonist
0,057  0,021  Factor III inhibitor
0,161  0,126  Dyrk kinase inhibitor
0,061  0,026  5 Hydroxytryptamine 2 agonist
0,089  0,055  Carcinogenic, group 2A
0,079  0,045  Telomerase inhibitor
0,109  0,076  Estrogen antagonist
0,143  0,110  Cytotoxic
0,084  0,051  Acetylcholine nicotinic antagonist
0,160  0,127  Glyceraldehyde-3-phosphate dehydrogenase inhibitor
0,042  0,009  Dopamine autoreceptor agonist
0,077  0,045  Histidine decarboxylase inhibitor
0,073  0,042  Neuronal nicotinic receptor antagonist
0,090  0,060  Antiviral (Hepatitis A)
0,148  0,118  Antineoplastic (bone cancer)
0,068  0,040  5 Hydroxytryptamine 1D antagonist
0,165  0,137  Vasodilator
0,083  0,058  Inducible nitric-oxide synthase inhibitor
0,094  0,070  Nitric-oxide synthase inhibitor
0,069  0,045  Dopamine agonist
0,031  0,007  Phosphodiesterase 6H inhibitor
0,031  0,007  Phosphodiesterase 6G inhibitor
0,164  0,141  Antipyretic
0,048  0,028  Dopamine D2 agonist
0,042  0,023  AMPA 4 receptor antagonist
0,137  0,119  Amyloid beta aggregation inhibitor
0,057  0,039  5 Hydroxytryptamine 6 antagonist
0,042  0,025  Acid-sensing ion channel blocker
0,040  0,023  Vesicle monoamine transporter inhibitor
0,073  0,057  Focal adhesion kinase 1 inhibitor
0,101  0,087  Alkylator
0,073  0,059  Narcotic antagonist
0,110  0,097  NADPH oxidase inhibitor
0,043  0,031  Glutamate (mGluR group III) antagonist
0,167  0,155  Cardiotonic
0,036  0,024  5 Hydroxytryptamine 3B antagonist
0,121  0,110  UGT1A4 substrate
0,057  0,048  5 Hydroxytryptamine 7 antagonist
0,072  0,063  Estrogen receptor alpha antagonist
0,106  0,097  Contraceptive female
0,100  0,092  Microtubule formation inhibitor
0,065  0,060  Dysmenorrhea treatment
0,023  0,018  Phosphodiesterase 6A inhibitor
0,122  0,119  Adenylate cyclase stimulant
0,146  0,143  Aldehyde oxidase inhibitor
0,113  0,110  Mutagenic
0,019  0,017  Imidazoline I1 receptor antagonist
0,109  0,107  Antihemorrhagic
0,093  0,092  Multidrug resistance-associated protein 1 inhibitor

